Pharmaust Limited (NUZ) Stock Statistics & Valuation Metrics

Pharmaust Limited has a market cap or net worth of AU$68.92M. The enterprise value is AU$77.06M.

Pharmaust Limited has 492,305,760 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmaust Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Pharmaust Limited is ―. Pharmaust Limited’s PEG ratio is ―.

In the last 12 months, Pharmaust Limited had revenue of ― and earned -1.71M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Pharmaust Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Pharmaust Limited upcoming earnings date is Aug 29, 2025, TBA Not Confirmed.

Pharmaust Limited as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Pharmaust Limited has paid ― in taxes.

Pharmaust Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Pharmaust Limited has ― in cash and marketable securities with 487.50K in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Pharmaust Limited is AU$0.44, which is 11.43% higher than the current price. The consensus rating is Moderate Buy